Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1822 (LINC01822) is a human long non-coding RNA (lncRNA) gene that does not encode a protein product[1]. As a member of the lincRNA class, it is thought to participate in gene regulatory processes, including transcriptional and epigenetic control, chromatin organization, and potentially in regulating cell growth, differentiation, or disease states, similar to other lincRNAs[5][6]. However, as of current knowledge, LINC01822 is not considered a well-established therapeutic target or biomarker, and its specific biological or pathological functions remain largely uncharacterized in the scientific literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1822 (LINC01822).